Cargando…

Microbiota, Fiber, and NAFLD: Is There Any Connection?

Gut microbiota can contribute to the development and progression of non-alcoholic fatty liver disease (NAFLD). In fact, some specific changes of gut microbiota are observed in patients in what is called dysbiota. There has been a lot of investigation by using a variety of interventions, including di...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Montes de Oca, Alejandra, Julián, María Teresa, Ramos, Analía, Puig-Domingo, Manel, Alonso, Nuria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600472/
https://www.ncbi.nlm.nih.gov/pubmed/33053631
http://dx.doi.org/10.3390/nu12103100
_version_ 1783603152231071744
author Pérez-Montes de Oca, Alejandra
Julián, María Teresa
Ramos, Analía
Puig-Domingo, Manel
Alonso, Nuria
author_facet Pérez-Montes de Oca, Alejandra
Julián, María Teresa
Ramos, Analía
Puig-Domingo, Manel
Alonso, Nuria
author_sort Pérez-Montes de Oca, Alejandra
collection PubMed
description Gut microbiota can contribute to the development and progression of non-alcoholic fatty liver disease (NAFLD). In fact, some specific changes of gut microbiota are observed in patients in what is called dysbiota. There has been a lot of investigation by using a variety of interventions, including diet, showing the possibility to modify components of gastrointestinal dysbiota towards healthy and multivariate microbiota to restore physiologic status. One of the main focuses has been dietary fiber (DF), in which most of its variants are prebiotics. The highest effective treatment for NAFLD is, so far, weight loss achieved by caloric restriction. DF supplementation with oligofructose facilitates weight loss, enhances the production of beneficial metabolites, decreases some pathogenic bacteria population by increasing Bifidobacteria, and has effects on intestinal barrier permeability. DF use has been associated with improvement in diverse metabolic diseases, including NAFLD, by modifying gut microbiota. Additionally, it has been shown that a higher insoluble fiber consumption (≥7.5 g/day) revealed improvements in 3 different scores of liver fibrosis. Further research is needed, but given the evidence available, it is reasonable to prescribe its consumption in early stages of NAFLD in order to prevent disease progression.
format Online
Article
Text
id pubmed-7600472
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76004722020-11-01 Microbiota, Fiber, and NAFLD: Is There Any Connection? Pérez-Montes de Oca, Alejandra Julián, María Teresa Ramos, Analía Puig-Domingo, Manel Alonso, Nuria Nutrients Review Gut microbiota can contribute to the development and progression of non-alcoholic fatty liver disease (NAFLD). In fact, some specific changes of gut microbiota are observed in patients in what is called dysbiota. There has been a lot of investigation by using a variety of interventions, including diet, showing the possibility to modify components of gastrointestinal dysbiota towards healthy and multivariate microbiota to restore physiologic status. One of the main focuses has been dietary fiber (DF), in which most of its variants are prebiotics. The highest effective treatment for NAFLD is, so far, weight loss achieved by caloric restriction. DF supplementation with oligofructose facilitates weight loss, enhances the production of beneficial metabolites, decreases some pathogenic bacteria population by increasing Bifidobacteria, and has effects on intestinal barrier permeability. DF use has been associated with improvement in diverse metabolic diseases, including NAFLD, by modifying gut microbiota. Additionally, it has been shown that a higher insoluble fiber consumption (≥7.5 g/day) revealed improvements in 3 different scores of liver fibrosis. Further research is needed, but given the evidence available, it is reasonable to prescribe its consumption in early stages of NAFLD in order to prevent disease progression. MDPI 2020-10-12 /pmc/articles/PMC7600472/ /pubmed/33053631 http://dx.doi.org/10.3390/nu12103100 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Pérez-Montes de Oca, Alejandra
Julián, María Teresa
Ramos, Analía
Puig-Domingo, Manel
Alonso, Nuria
Microbiota, Fiber, and NAFLD: Is There Any Connection?
title Microbiota, Fiber, and NAFLD: Is There Any Connection?
title_full Microbiota, Fiber, and NAFLD: Is There Any Connection?
title_fullStr Microbiota, Fiber, and NAFLD: Is There Any Connection?
title_full_unstemmed Microbiota, Fiber, and NAFLD: Is There Any Connection?
title_short Microbiota, Fiber, and NAFLD: Is There Any Connection?
title_sort microbiota, fiber, and nafld: is there any connection?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600472/
https://www.ncbi.nlm.nih.gov/pubmed/33053631
http://dx.doi.org/10.3390/nu12103100
work_keys_str_mv AT perezmontesdeocaalejandra microbiotafiberandnafldisthereanyconnection
AT julianmariateresa microbiotafiberandnafldisthereanyconnection
AT ramosanalia microbiotafiberandnafldisthereanyconnection
AT puigdomingomanel microbiotafiberandnafldisthereanyconnection
AT alonsonuria microbiotafiberandnafldisthereanyconnection